基于循证医学方法的艾迪注射液超适应证药物利用评价

目的：建立艾迪注射液超适应证用药标准，为临床合理使用该药提供参考。方法：（1）建立标准：分析2016年某院艾迪注射液使用情况和主要适应证，制定检索策略，检索The Cochrane Library、Pubmed、ELSEVIER、CNKI等数据库，运用GRADE profiler 3.6软件对系统评价进行分析，运用RevMan 5.3软件对随机对照试验（RCT）进行meta分析，对超适应证用药进行循证评价并建立标准。（2）依据该标准对抽取病历进行点评，提出问题并进行整改，比较干预前后效果。结果：文献检索后纳入10篇系统评价，4篇RCT。艾迪注射液联合某些化疗方案可用于胃癌、结直肠癌，不建议用于食管癌等疾病。依据以上标准干预我院艾迪注射液用药，取得了良好效果。结论：基于循证医学方法建立艾迪注射液超适应证用药标准切实可行。

Evidence-based drug use evaluation of Aidi injection in super indications

OBJECTIVE To establish the criteria of Aidi injection for off-label use and provide a reference for rational clinical use of the drug.METHODS (1) Establishment of criteria:We analyzed the use and main indications of Aidi injection in a hospital in 2016 and then formulated search strategy.Databases including the Cochrane Library,Pubmed,ELSEVIER,CNKI and other databases were searched.GRADE profiler 3.6 software was used to analyze the systematic review and RevMan 5.3 software was used to perform a meta-analysis of randomized controlled trials (RCTs).Evidence-based appraisal was conducted for off-label and the criteria was established.(2) The medical records were reviewed by the established criteria and concerned questions were raised and rectification were made.Effects before and after intervention were compared.RESULTS Ten systematic reviews and four RCTs were included after the literature search.Aidi injection combined with certain chemotherapy regimens can be used for gastric cancer,colorectal cancer,and is not recommended for diseases such as esophageal cancer.According to the above criterias,we intervened in the use of Aidi injection in our hospital and achieved good results.CONCLUSION It is feasible to establish evaluation standards for off-label use of aidi injection by applying evidence-based medicine method.